These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32281763)

  • 1. [Management of hemodialysis patient subject to medical-nuclear investigation].
    Granata A; Sessa C; Fiorini F; Randone S; Di Nicolò P; Zanoli L; Piranio S
    G Ital Nefrol; 2020 Apr; 37(2):. PubMed ID: 32281763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profound mishandling of protein glycation degradation products in uremia and dialysis.
    Agalou S; Ahmed N; Babaei-Jadidi R; Dawnay A; Thornalley PJ
    J Am Soc Nephrol; 2005 May; 16(5):1471-85. PubMed ID: 15800128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. We Use Impure Water to Make Dialysate for Hemodialysis.
    Upadhyay A; Jaber BL
    Semin Dial; 2016 Jul; 29(4):297-9. PubMed ID: 27061684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant versus natural human 111In-beta2-microglobulin for scintigraphic detection of Abeta2m amyloid in dialysis patients.
    Schäffer J; Burchert W; Floege J; Gielow P; Kionka C; Linke RP; Weiss EH; Shaldon S; Koch KM
    Kidney Int; 2000 Aug; 58(2):873-80. PubMed ID: 10916113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of nutrition in dialysis patients and chronic uremic patients].
    Liu H; Duan X; Li G
    Zhonghua Nei Ke Za Zhi; 1997 Nov; 36(11):727-30. PubMed ID: 10451942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear medicine studies in the dialysis patient.
    Meller J; Sahlmann CO; Becker W
    Semin Dial; 2002; 15(4):269-76. PubMed ID: 12191027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protein-bound uremic toxins: efficacy of elimination during hemodialysis and CAPD].
    Krajewska M; Weyde W; Klinger M
    Pol Arch Med Wewn; 2003 Apr; 109(4):411-5. PubMed ID: 12931494
    [No Abstract]   [Full Text] [Related]  

  • 8. Increasing the removal of protein-bound uremic toxins by liposome-supported hemodialysis.
    Shi Y; Wang Y; Ma S; Liu T; Tian H; Zhu Q; Wang W; Li Y; Ding F
    Artif Organs; 2019 May; 43(5):490-503. PubMed ID: 30375673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of gastric emptying in patients with chronic renal failure on continuous ambulatory peritoneal dialysis using 99mTc-solid meal.
    Hubalewska A; Stompór T; Płaczkiewicz E; Staszczak A; Huszno B; Sułowicz W; Szybiński Z
    Nucl Med Rev Cent East Eur; 2004; 7(1):27-30. PubMed ID: 15318307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excess morbidity in patients starting uremia therapy without prior care by a nephrologist.
    Ifudu O; Dawood M; Homel P; Friedman EA
    Am J Kidney Dis; 1996 Dec; 28(6):841-5. PubMed ID: 8957035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of bone scans in uremic patients treated with intermittent peritoneal dialysis or hemodialysis.
    Plotast H; Grzegorzewska AE; Junik R; Sowinski J; Gembicki M
    Perit Dial Int; 1996; 16 Suppl 1():S312-6. PubMed ID: 8728214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to measure residual renal function in patients on maintenance hemodialysis.
    Lew SQ
    Adv Ren Replace Ther; 1994 Jul; 1(2):185-93. PubMed ID: 7614319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is low dialysate potassium ever indicated in outpatient hemodialysis?
    Moledina D; Geller D
    Semin Dial; 2014; 27(3):263-5. PubMed ID: 24635442
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vitamin K1 and C metabolism in uremia during hemodialysis].
    Bakaev VV; Khomenko VF
    Urol Nefrol (Mosk); 1991; (1):40-3. PubMed ID: 1858205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of small solute clearance in hemodialysis.
    Huang Z; Clark WR; Gao D
    Semin Dial; 2005; 18(1):30-5. PubMed ID: 15663761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and dietary indicators associated with uremic status in hospitalized dialysis patients.
    Steiber AL; Weatherspoon LJ; Handu D
    J Ren Nutr; 2002 Jan; 12(1):49-54. PubMed ID: 11823994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of nervous tissue transketolase to the neuropathy in chronic uremia.
    Sterzel RB; Semar M; Lonergan ET; Treser G; Lange K
    J Clin Invest; 1971 Nov; 50(11):2295-304. PubMed ID: 5096513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart and soft-tissue uptake of Tc-99m MDP in a hemodialysis patient.
    Sahin A; Seven B; Yildirim M; Varoglu E
    Clin Nucl Med; 2004 Dec; 29(12):854-5. PubMed ID: 15545907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.